Patients and civic groups call for compulsory license over Roche’s AIDS drug

Published: 2009-04-03 06:59:00

Updated: 2009-04-03 06:59:00

The government should break the Swiss drug giant Roche’s patent of AIDS drug Fuzeon by applying a "compulsory license" in a bid to protect the public interest, according to Korean patients and activists.

In a forum hosted by the Korean Intellectual Property Office, pharmacist Kwon Mi-ran of a ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK